Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Malignant hyperthermia: how important after 30 years.

F R Ellis1

  • 1University Department of Anesthesia, St. James's University Hospital, Leeds, UK.

Acta Anaesthesiologica Belgica
|January 1, 1990
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

European Malignant Hyperthermia Group guidelines for investigation of malignant hyperthermia susceptibility.

British journal of anaesthesia·2015
Same author

Recognizing and managing a malignant hyperthermia crisis: guidelines from the European Malignant Hyperthermia Group.

British journal of anaesthesia·2010
Same author

Plasma and erythrocyte membrane long chain polyunsaturated fatty acids in endogenous depression.

Neurochemistry international·2010
Same author

Multiple interacting gene products may influence susceptibility to malignant hyperthermia.

Annals of human genetics·2001
Same author

Segregation of malignant hyperthermia, central core disease and chromosome 19 markers.

British journal of anaesthesia·2000
Same author

Genetic heterogeneity and HOMOG analysis in British malignant hyperthermia families.

Journal of medical genetics·1998
Same journal

Intraoperatively diagnosed tracheal tear during a parathyroidec- tomy with previously undiagnosed tracheomalacia: a case report.

Acta anaesthesiologica Belgica·2018
Same journal

Ultrasound-guided axillary brachial plexus blocks for pseudo- syndactyly surgeries in a patient with epidermolysis bullosa: a case report.

Acta anaesthesiologica Belgica·2018
Same journal

Opioid-free anesthesia: what about patient comfort? A prospective, randomized, controlled trial.

Acta anaesthesiologica Belgica·2018
Same journal

Intraoperative administered tramadol reduces the need for piritramide in the immediate postoperative period in children undergoing adenotonsillectomy: A retrospective observational study.

Acta anaesthesiologica Belgica·2018
Same journal

Preoperative frailty assessment: a review.

Acta anaesthesiologica Belgica·2018
Same journal

Remifentanil PCIA during labor and delivery: can we improve maternal monitoring?.

Acta anaesthesiologica Belgica·2018
See all related articles

Malignant hyperthermia (MH), a condition recognized for over 30 years, has seen shifts in its apparent incidence and importance. Future anesthetic practice will be shaped by MH developments and genetic screening advancements.

Area of Science:

  • Anesthesiology
  • Pharmacogenetics
  • Medical Genetics

Background:

  • Malignant hyperthermia (MH) is a severe, inherited hypermetabolic myopathy.
  • Recognized for over three decades, MH poses a significant risk during anesthesia.
  • The understanding of MH's incidence and clinical importance has evolved.

Purpose of the Study:

  • To discuss the historical developments and future role of MH in anesthesiology.
  • To evaluate the impact and significance of genetic screening for MH.
  • To provide an updated perspective on managing MH risk in clinical practice.

Main Methods:

  • Review of historical data and clinical literature on malignant hyperthermia.
  • Analysis of trends in MH incidence and recognition.

Related Experiment Videos

  • Discussion of advancements in genetic testing and screening protocols for MH susceptibility.

    • Main Results:

    • The apparent incidence and perceived importance of MH have changed over time.
    • Genetic screening offers a proactive approach to mitigate MH risks.
    • Understanding MH pathophysiology is crucial for anesthetic management.

    Conclusions:

    • Malignant hyperthermia remains a critical consideration in anesthesiology.
    • Genetic screening is increasingly vital for safe anesthetic practice.
    • Continued research and vigilance are necessary to address MH challenges.